Our Founder

DR V.K Bhalla

Over 30 years in senior positions in Pharmaceutical Industry – 22 years in finished dosage forms, 8 years in API. Total Quality Management, Projects & Business Management (As Profit Center Head)

  • Established Quality Systems in accordance with international Standards including EDQM, TGA and USFDA.Dr. V.K. Bhalla
  • Preparation & filing of Drug Master Files for API & Dossiers (formulations) for registration in various countries.
  • Authored / Reviewed more than 100 Drug Master Files & Dossiers for API and submitted to  – EDQM, USFDA, MCA-UK, Irish Board of Medicine, Canadian Drug Authorities, TGA – Australia, Federal Institute for Drugs and Medicinal Products, Germany etc.
  • Led the Companies successfully through inspections and / or approvals:


EDQM, USFDA, MCA – UK, Irish Board of Medicine, TGA – Australia, Certificates of Suitability, National Board of Health & Medicine, SWEDEN (on behalf of UNICEF WHO), MCC – South Africa.

  • The Company (KAPL) won five times IDMA Quality Excellence Award.
  • ISO 9001: 1994 &ISO 9001: 2000 accreditation.


FORMULATIONS: Setting up of Manufacturing Facilities for Sterile & Non-sterile Dosage Forms as per cGMP requirements.

API & INTERMEDIATES: Setting up and up-gradation of Manufacturing Facilities as per cGMP requirements.


Management: Advanced Management Program (one month residential Course) for Senior Public Sector Executives at Administrative Staff College of India, HYDERABAD.

Biotechnology: Advanced H I V testing at Genetic Systems Corp., Seattle, U S A, Advanced Immunological Techniques at All India Institute of Medical Sciences, New Delhi

ISO:  ISO 9001 Auditor / Lead Auditor Training Course by TQMI. ISO 9001:2000 Transition Auditor Training Course by BVQI

ANDA: Orientation at TOR Pharma, Canada


Nine Publications

Speaker at 52nd IPC congress at Hyderabad

Faculty at Workshop on GMP & Quality Assurance at PERD center, Ahmedabad


Ph.D.( Microbiology) in 1979, from All India Institute of Medical Sciences, New Delhi

M.Sc (Hon’s.), Microbiology from Punjab University, Chandigarh

B.Sc. (Hon’s) – with distinction, in Microbiology


September 2002 – Present

Director, CPC India Limited

February 2001 – September 2002

 President (Corp. Quality), Dishman Pharmaceuticals & Chemicals Ltd. Ahmedabad

In Technical Collaboration with M/S Solvay Pharmaceuticals, Netherlands for the manufacturing of Eprosartan mesylate

July 1997 – March 2001

Vice President (Corporate Head Regulatory and Quality – API & Formulations), Nicholas Pharma India Ltd (4th largest pharmaceutical company in INDIA

June 1995 – July 1997

Senior General Manager & Head Total Quality Management (API & Formulations), SOL Pharmaceuticals Ltd, Hyderabad.

USFDA inspected facility for Sulphamethoxazole

April 1991 – June 1995

General Manager / Dy General Manager (Immunodiagnostics), Karnataka Antibiotics & Pharmaceuticals Ltd., Bangalore

Tie-up with M/S Sanofi Diagnostic Pasteur, Paris France for the marketing and subsequently manufacturing of AIDS Kits in India

June 1983 – April 1991

Dy General Manager/Head Total Quality Management (Formulations), Karnataka Antibiotics & Pharmaceuticals Ltd., Bangalore

 A subsidiary of HAL Pimpri, Pune  – Manufacturing Injections, Tablets, Capsules, dry syrups, liquid orals,  Veterinary products

Approval by National Board of Health & Welfare, Sweden

(On behalf of UNICEF WHO)

IDMA quality excellence award – 5 times

Nov. 1977 – June 1983

Head Microbiology, Pharmacology (Quality Control), IDPL –  Gurgaon